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AbstrACt
Introduction Weight management interventions in 
research studies and in clinical practice differ in length, 
advice, frequency of meetings, staff and cost. Very few 
real-world programmes have published patient-related 
outcomes, and those that have published used different 
ways of reporting the information, making it impossible to 
compare interventions and further develop the evidence 
base. Developing a core outcome set for behavioural 
weight management programmes (BWMPs) for adults with 
overweight and obesity will allow different BWMPs to be 
compared and reveal which interventions work best for 
which members of the population.
Methods and analysis An expert group, comprised of 40 
people who work in, refer to, or attend BWMPs for adults 
with overweight and obesity, will be asked to decide which 
outcomes services should report. An online Delphi process 
will be employed to help the group reach consensus as to 
which outcomes should be measured and reported, and 
which definitions/instruments should be used in order to 
do so. The first stage of the Delphi process (three rounds 
of questionnaires) will focus on outcomes while the second 
stage (three additional rounds of questionnaires) will focus 
on definition/instrument selection.
Ethics and dissemination Ethical approval for this 
study has been received from the University of Glasgow 
College of Medical, Veterinary and Life Sciences Ethics 
Committee. With regard to disseminating results, a report 
will be submitted to our funding body, the Chief Scientist 
Office of the Scottish Government Health Department. In 
addition, early findings will be shared with Public Health 
England and Health Scotland, and results communicated 
via conference presentations, peer review publication and 
our institutions’ social media platforms.
IntroduCtIon  
Both the National Institute for Health and 
Care Excellence (NICE)1 and Scottish Inter-
collegiate Guidelines Network2 guidelines 
outline the intervention components to be 
included in a community weight manage-
ment programme, namely calorie restriction, 
increased physical activity and behavioural 
interventions. These have proven efficacy 
from randomised controlled trials.3 However, 
their implementation in practice is inconsis-
tent with mapping exercises in Scotland4 and 
England5 showing wide variation in services 
in terms of inclusion criteria, referral routes, 
delivery format, length and cost. Few real 
life services have published data and when 
they do publish, results can be poor with low 
levels of completion and ‘success’, and lack of 
longer term outcomes.
The NICE guidance, ‘Weight management: 
lifestyle services for overweight or obese 
adults’,1 identified a number of evidence 
gaps. These included, reliance on studies 
with short follow-up, collection of data at 
limited time points, small sample sizes, demo-
graphic samples that limit the ability to gener-
alise, non-reporting of reasons for people 
strengths and limitations of this study
 ► The major strength of this study is that it is the first 
of its kind and development of a core outcome set for 
behavioural weight management programmes for 
adults with overweight and obesity is much needed 
in order to standardise reporting which, in turn, will 
lead to a better evidence base and improvements in 
weight management provision.
 ► It is a limitation that this study is wholly based in 
the UK as the results may need some adaptation to 
be suited to real-world programmes set within other 
healthcare systems.
 ► The recognised method for core outcome set devel-
opment, the Delphi method, will be used to garner 
opinions from a wide range of individuals with ex-
pertise in behavioural weight management.
 ► Review of all existing qualitative research studies 
will not be undertaken when generating the initial 
list of outcomes. However, qualitative work will be 
performed during core outcome set development as 
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dropping out and lack of evidence regarding the effect of 
population characteristics, such as age, gender and socio 
economic status, on the effectiveness of a service. They 
noted a lack of comparisons between behavioural weight 
management programmes (BWMPs) in the UK. This lack 
of an evidence base means that it is not possible to issue 
clear guidance as to which services are cost effective for 
which population groups.
Public Health England (PHE) has created a standard 
evaluation framework (SEF)6 to aid the evaluation of 
real-world weight management programmes. However, 
in their 2015 weight management mapping exercise,5 
PHE reported that only 46% of adult weight manage-
ment programmes use the SEF and, as it simply suggests 
areas for reporting and potential methods of analysis, 
there is a huge gap in standardised reporting. PHE had 
intended to analyse data from services but analysis was 
not possible due to the heterogeneity of reporting which 
included kilograms, % weight loss, average number of 
completers achieving 5% wt loss, body mass index (BMI) 
and more.5 With regard to research studies, evidence 
suggests similar heterogeneity in terms of the reporting 
of outcomes.7
In an attempt to address this reporting issue, PHE 
issued a minimum dataset8 which provides an important 
core outcome recommendation for England, stipulating 
collection of certain demographics, service details, 
BMI and well-being at baseline, on completion of the 
programme and at 6 months and 12 months postpro-
gramme. A data collection tool provides information 
to support the standardisation of these data collection 
practices. This minimum dataset will be used to support 
PHE’s recently released document on adult tier 2 wt 
management service key performance indicators (KPIs)9 
which provides advice as to how weight status and service 
compliance should be reported and measured.
The study described herein has been funded through a 
Chief Scientist Office of the Scottish Government Health 
Department grant and will serve to further validate and 
build on the PHE minimum dataset8 and KPI document,9 
while also informing a similar framework for Scotland. 
In addition, our research will provide much needed 
consensus on the measurements that should be used, such 
as questionnaires, something currently not covered in the 
PHE minimum dataset8 or KPI document.9 Overall, this 
work will ensure more consistency in the measurement 
of the effectiveness of adult weight management services, 
leading to a better evidence base from which to identify 
which services are effective across a range of settings.
Recently, a core outcome set for bariatric and meta-
bolic surgery was successfully developed using consensus 
methodology.10 However, outcomes, including perioper-
ative outcomes and postoperative complications, are not 
relevant for reporting from BWMPs. Therefore, the aim 
of this study, which will run from November 2017 until 
November 2018, is to gain expert consensus opinion 
on the core outcomes that should be reported from 
behavioural weight management interventions for adults 
with overweight and obesity in real-world clinical practice 
as well as within research studies.
The specific study objectives are to:
1. Review the list of outcomes previously reported in the 
PHE SEF,6 minimum dataset8 and KPI document9;
2. Identify additional outcomes reported in studies of 
structured, sustained, multicomponent weight man-
agement programmes for adults from a systematic re-
view of the literature;
3. Select outcomes for inclusion in the core dataset using 
consensus methodology;
4. Select definitions/instruments for measuring chosen 
outcomes using consensus methodology.
MEthods And AnAlysIs
Identification of outcomes
We will generate a list of outcomes by review of the 
PHE SEF,6 which was itself developed from a systematic 
review of the literature/focus groups, and from the PHE 
minimum dataset8 and KPI document9 which were devel-
oped through expert consensus and evidence from the 
peer review and grey literature.
Further outcomes will be selected by a review of included 
studies in the systematic review, ‘The clinical effectiveness 
of long-term weight management schemes for adults’ by 
Hartmann-Boyce et al,7 conducted during the develop-
ment of NICE guidance.1 This systematic review7 assessed 
the effects of multicomponent BWMPs in overweight and 
adults with obesity which may be applicable in the UK. 
To be considered a multicomponent BWMP, the compo-
nents of the programme had to include diet, physical 
activity and behavioural therapy (for example, counsel-
ling sessions). The scope included commercial weight 
loss programmes and non-commercial programmes, such 
as those delivered in primary care settings (for example, 
in General Practice).7 It updated and expanded on an 
existing systematic review published in 2011 by Loveman 
et al3 and used similar methods. The Loveman systematic 
review3 sought to assess the long-term clinical effective-
ness and cost-effectiveness of multicomponent weight 
management schemes for adults in terms of weight loss 
and maintenance of weight loss.
Additional outcomes will be identified by updating 
the Hartmann-Boyce systematic review,7 using the same 
inclusion criteria but extending search dates so that 
studies from 1/11/2012 until 30/09/17 are included. 
Search and selection criteria for the systematic review 
are identical to those of Hartmann-Boyce.7 With regard 
to database searches, Hartmann-Boyce7 searched 
BioSciences Information Service of Biological Abstracts 
(BIOSIS), the Cochrane Database of Systematic Reviews, 
Cochrane Controlled Register of Trials (CENTRAL), the 
Conference Proceedings Citation Index, the Database 
of Abstracts of Reviews and Effects, Embase, the Health 
Technology Assessment database, Medline, PsychInfo 
and Science Citation Index for references relating to 
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from three additional sources: reference lists in system-
atic reviews, documents received via the NICE call for 
evidence and studies excluded from Loveman3 that they 
wished to re-examine. Studies selected for inclusion had 
to be structured, sustained, multicomponent adult weight 
management programmes with interventions which 
were a combination of diet and physical activity with a 
behaviour change strategy to influence lifestyle. In addi-
tion, programmes were required to include a follow-up 
of more than 12 months and be delivered in the health 
sector, in the community or commercially (ie, applicable 
to the National Health Service; NHS).
Two review authors will independently assess the 
abstracts of studies resulting from our literature search. 
Full text copies of studies appearing to meet the inclu-
sion criteria will be further independently assessed by the 
two reviewers. Following discussion, agreement will be 
reached as to which studies to include. Any new outcomes 
will then be identified from the selected studies from 
both Hartmann-Boyce7 and the updated review.
Identification of instruments
By review of the studies identified during the system-
atic reviews previously described, we will list instruments 
and definitions for selected outcomes. The study inves-
tigators will review this list and add any further suitable 
instruments.
data analysis and presentation
For analysis purposes, the data will be tabulated so that 
the outcomes and instruments to be included in our 
Delphi are listed and the study/studies from which they 
were identified are displayed. Outcomes and instruments 
will be grouped under appropriate domains following 
review of selected outcomes.
Patient and public involvement
We will develop our core outcome set by means of 
consensus from an expert group. The sampling frame will 
aim to include members of the public with experience of 
NHS, local authority or commercial adult BWMPs in the 
UK, academics/policy makers/commissioners working in 
weight management, staff currently involved in delivering 
a BWMP for adults (without significant policy involve-
ment) and primary care staff (referrers). Consensus 
methodology will ensure that the opinions and prefer-
ences of members of the public will be given the same 
weighting as those of the other experts.
There is no published agreement on the optimal size of 
an expert group; pragmatism is required while ensuring 
a range of opinions is garnered. Experience suggests a 
greater than 80% completion rate of Delphi question-
naires.10 11 We will preapproach potential volunteers to 
get agreement to participate from 10 members of the 
public, 20 academics/policy makers/commissioners, 
20 wt management staff and 10 primary care staff. Forty 
experts will complete each of the two separate Delphi 
processes.
For the first Delphi process (stage 1, outcome selec-
tion), 10 members of the public, 10 academics/policy 
makers/commissioners, 10 wt management staff and 10 
primary care staff will be invited to participate.
For the second Delphi (stage 2, instrument selec-
tion), 20 academics/policy makers/commissioners and 
20 wt management staff will be invited to participate 
with further members recruited if any of the original 
group (the 10 from each group who completed stage 1) 
have dropped out after the stage 1 Delphi. The stage 2 
Delphi will involve reading papers, looking at metrics 
and assessing validity of instruments/questionnaires. As 
in depth knowledge of academic literature and reporting 
tools is required, this stage of the Delphi process will be 
restricted to academics/policy makers/commissioners 
and weight management staff.
A small monetary incentive (a £35 gift voucher for 
either John Lewis or Amazon, depending on preference) 
will be offered to members of the public and primary care 
staff as this study is not of any direct benefit to them and 
could not be considered part of their role.
Staff working in weight management, academics/
policy makers/commissioners and primary care staff will 
be recruited by email from the investigators and their 
personal contacts, and also via an email from the Asso-
ciation for the Study of Obesity. An information letter 
outlining the study will be attached to emails. On regis-
tering interest in our study, we will ask volunteers from 
these groups to provide us with information as to their 
role and geographical location within the UK.
Members of the public will be recruited by email from 
the Association for the Study of Obesity (which has lay 
members) and from professional contacts (a number of 
weight management programmes have lay members on 
steering committees). An information letter outlining the 
study will be attached to emails. (The information letter 
for the public will be written in lay language and will there-
fore differ slightly to the information letter for the other 
groups.) We have also registered with the NIHR People in 
Research website (https://www. peopleinresearch. org/) 
where our study will be advertised (following review to 
ensure suitability for a lay audience). Our information 
letter will be available to download from this website. On 
registering interest in our study, a ‘job description’ pro 
forma will be sent to members of the public via email. 
They will be asked to complete this pro forma and return 
it to us by email. The pro forma will provide us with infor-
mation as to their gender, age, geographical location and 
experience of BWMPs.
In addition, Facebook and Twitter will be used to 
recruit members of the public, weight management 
staff, academics/policy makers/commissioners and 
primary care staff. Facebook posts and Tweets will link 
to a Mailchimp recruitment page where volunteers 
will be able to register their interest. On doing so, they 
will receive the appropriate information letter. Weight 
management staff, academics/policy makers/commis-
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with information as to their role and geographical loca-
tion within the UK, and members of the public will be 
asked to complete the job description pro forma.
Following provision of information regarding role and 
geographical location from weight management staff, 
academics/policy makers/commissioners and primary 
care staff, and the return of completed pro formas from 
members of the public, selection of volunteers to partic-
ipate will commence. Selection will be based on our 
sampling framework which is outlined below. Volunteers 
will be sent an email to thank them for their interest and 
inform them if they have been selected to participate 
or not. A list of selected volunteers’ names and email 
addresses will then be sent to Clinvivo ( www. clinvivo. com, 
a spin-out company of the University of Warwick) who 
will be conducting the Delphi process. Clinvivo will then 
contact these individuals by email, providing a link to the 
online Delphi questionnaire and instructions as to how to 
complete it.
On completion of the study, all participants (including 
members of the public) will be sent (by email) a copy 
of the final outcome and definition/instrument sets. 
In addition, where consent has been given, participants 
(including members of the public) will be named as 
contributors in the results publication.
Sampling framework
To ensure our volunteers are a representative UK group, 
of the 20 wt management staff selected, at least 50% will be 
from England. Similarly, at least 50% of the 20 academic/
policy maker/commissioner group will be from England. 
Eight of the 20 (40%) will be academics, six of the 20 
(30%) will be policy makers and six of the 20 (30%) will 
be commissioners. At least 50% of the 10 primary care 
staff selected will also be from England. With regard to 
members of the public, more than 50% will have expe-
rience of commercial BWMPs, more than 50% will be of 
working age, more than 30% will be male and less than 
30% will be from any one region of the UK.
delphi survey
In order to develop our core outcome dataset, Delphi 
methodology will be used to gain consensus from our 
expert group. Two Delphis (stage 1 and stage 2) will 
be carried out using an online system developed and 
conducted by Clinvivo. Each Delphi will be carried out 
online over three sequential rounds with the same group 
of participants (figure 1). For both stage 1 and stage 2 
Delphis, only those who complete a questionnaire in 
round 1 will be eligible to participate in round 2, and only 
those who complete round 2 will be eligible to participate 
in round 3.
The stage 1 Delphi will involve asking each expert to 
score the importance of an outcome measure for use 
in weight management service outcome reporting. The 
scale will run from 1 to 9 with 1–3 indicating that the 
outcome is unimportant, 4–6 indicating that it is neither 
unimportant nor important and 7–9 indicating that it is 
important.
During the stage 2 Delphi, experts will be asked to score 
the appropriateness of outcome definitions and instru-
ments for measurement of outcomes. Again, this will be 
done using a 1–9 scale with 1–3 indicating that the defi-
nition/instrument is inappropriate, 4–6 indicating that 
it is neither appropriate nor inappropriate and 7–9 indi-
cating that it is appropriate.
statistical analysis
To assess disagreement and importance/appropriate-
ness (and thus define consensus) the Research and 
Figure 1 Schematic outlining the two stage Delphi study. In order to develop a core outcome set and definition/instrument set, 
Delphi methodology will be used to gain consensus from expert groups. Two Delphis (stage 1 and stage 2) will be carried out 
online over three rounds of questionnaires. The stage 1 Delphi will focus on development of a core outcome set. The stage 2 
Delphi will focus on corresponding definition/instrument selection. KPI, key performance indicator; PHE, Public Health England; 
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Development (RAND)/University of California Los 
Angeles (UCLA) appropriateness method will be used.11 
This involves calculating the median score, the interper-
centile range (IPR, 30th and 70th) and the interpercen-
tile range adjusted for symmetry (IPRAS), for each item 
being rated.
Fitch et al11 first explored using the IPR alone in an 
attempt to develop a method that reproduced ‘classic’ 
RAND definitions on panels that were multiples of 
three (which was typical in RAND’s early consensus 
studies), but could also be extended to larger panel sizes. 
They found that in cases when agreement was good, 
the IPR should be narrow and in cases where there was 
disagreement, the IPR should be wide. However, an 
in-depth examination of the cases of disagreement identi-
fied by the IPR led to the discovery that when the ratings 
were symmetric, the IPR required to label an indication 
as disagreement was smaller than when the ratings were 
asymmetric, with respect to the middle. To overcome this, 
they developed the IPRAS which includes a correction 
factor for asymmetry (equation 1).
Equation 1
IPRAS=IPRr + (AI x CFA)
Where IPRr is the IPR required for disagreement when 
perfect symmetry exists, AI is the asymmetry index and 
CFA is the correction factor for asymmetry.
The IPRAS is the threshold beyond which the IPR for a 
particular item indicates disagreement. Using the IPRAS 
and the IPR to judge disagreement reproduces ‘classic’ 
RAND definitions when applied to panels made up of 
multiples of three, but can also be applied to panels of 
any size.11 Variations on the stringencies of definitions 
of disagreement exist12 but similar examples of Delphi 
studies in health services research have used the classic 
definition.13–18 In equation 1, the optimal values for IPRr 
and CFA were derived following empirical work on a 
9-point scale.11 Fitch et al found that using values of 2.35 
and 1.5 best reproduced the ‘classic’ definitions of agree-
ment. These values will be used in this analysis. We will 
calculate AI as the distance between the central point of 
the IPR (p30 +p70/2) and the central point of the scale 
(ie, 5 on a 1–9 point scale.).
The IPRAS threshold is dependent on the symmetry 
of ratings about the median. Thus, each item requires 
a different IPRAS to be calculated. Consequently, the ith 
indication is rated with disagreement if the IPRi>IPRASi. 
In previous Delphi studies some have calculated the ratio 
of these: the disagreement index.14 16 18 If the disagree-
ment index was less than 1.0, it indicated there was no 
disagreement for the item in question. However, this is 
problematic in terms of interpretation because in the 
case that the IPR is zero, then the ratio is zero, which can 
cause confusion. For this reason we will present IPR and 
IPRAS values and simply comment on whether or not 
there is disagreement (ie, when IPRi>IPRASi).
Judgement of appropriateness/importance also follows 
the classic RAND definitions, and this is assessed simply 
as whether the median rating falls between 1 to 3 (inap-
propriate/unimportant), 4 and 6 (unsure) or 7 and 9 
(appropriate/important).
At the end of each Delphi round, the median rating 
will be determined for individual outcomes/instruments 
and the distribution of ratings summarised in analysis 
conducted by Clinvivo and transferred to our research 
group (figure 1).
During both stage 1 and stage 2, participants will be 
given 2 weeks to complete each round of the Delphi 
and will be reminded of the deadline for completion 
before starting the process. Participants will also be sent a 
reminder email 1 day before the deadline for each round.
Stage 1, round 1 Delphi
The first Delphi study (stage 1) will be to select outcomes 
for inclusion in the core dataset. Full instructions will 
be provided to the expert group prior to completion of 
stage 1 questionnaires. Outcomes will be grouped under 
appropriate domains (broadly based on the PHE SEF6 
and broadly following the weight management chrono-
logical pathway) and full definitions of each domain and 
outcome will be provided in lay language. Participants 
will be asked to rate each outcome in turn using the 1–9 
scale. During round 1, there will be an option for adding 
free text outlining reasons for any given rating and also 
for suggesting possible additional outcomes.
Analysis of stage 1, round 1
Additional outcomes listed by participants will be 
reviewed by two members of the study team (RMM and 
JL) to ensure they represent new outcomes. All outcomes, 
excluding any rated unimportant by consensus and 
including any new outcomes, will be carried forward to 
round 2.
Stage 1, round 2 Delphi
In round 2, all experts will be asked to rate outcomes 
again. They will be shown their previous rating, the 
median expert group rating and any free text comments 
in the hope of ratings reaching a consensus. Experts will 
be asked to strongly consider the priority outcomes for 
weight management reporting in this round. Additional 
questions will be added as to the appropriate number of 
items to be included in the core outcome set.
Analysis of stage 1, round 2
All outcomes, excluding any rated unimportant by 
consensus and including any new outcomes, will be 
carried forward to round 3.
Stage 1, round 3 Delphi
In round 3, all experts will be asked to rate outcomes for 
the final time. They will be shown their previous rating, the 
median expert group rating and any free text comments 
in the hope of ratings reaching a consensus. Should it 
be the case that a large number of outcomes are being 
rated as important at this stage, the need to decide which 
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reporting will be reinforced to experts and they will be 
asked to rate only these priority outcomes as important. 
This will ensure development of a core outcome set of a 
manageable/practical size.
Analysis of stage 1, round 3
Using the consensus on the outcome set size and impor-
tance of outcomes, an outcome set will be developed by 
the study team using the results of the Delphi.
Stage 2, round 1 Delphi
The second Delphi study (stage 2) will be for definition/
instrument selection. Selection of instruments for inclu-
sion in the stage 2 Delphi will be informed, as previ-
ously stated, by results/ratings/suggestions from stage 
1, systematic review and input from co-investigators (LJE 
and SAS).
Full instructions will be provided prior to completion 
of stage 2 questionnaires. As per stage 1, instruments will 
be grouped under appropriate domains and full defi-
nitions of each instrument will be provided. As stated, 
participants will be asked to rate each instrument in turn 
using a 1–9 scale of appropriateness (rather than impor-
tance). During the first round of the stage 2 instrument 
selection process, there will be an option for adding 
text outlining reasons for any given rating and also for 
suggesting possible additional instruments for measuring 
or defining outcomes.
Analysis of stage 2, round 1
Additional instruments listed by participants will be 
reviewed by two members of the study team (RMM and 
JL) to ensure they represent new instruments. All instru-
ments, excluding those rated inappropriate by consensus 
and including any new instruments, will be carried 
forward to round 2.
Stage 2, round 2 Delphi
In round 2, all experts will be asked to rate instruments 
again. They will be shown their previous rating, the 
median expert group rating and any free text comments 
in the hope of ratings reaching a consensus. Experts will 
be encouraged to rate instruments in a way that shows 
their preferences.
Analysis of stage 2, round 2
It may be that after round 2 an instrument set can be 
formed. Only those instruments related to an outcome 
for which there is no established consensus will be carried 
over to round 3.
Stage 2, round 3 Delphi
In round 3, all experts will be asked to select instru-
ments for the final time. They will be shown their 
previous rating, the median expert group rating and 
any free text comments in the hope of ratings reaching 
a consensus. In this round they will be asked to select 
the most appropriate instrument for each outcome in a 
binary format.
Analysis of stage 2, round 3
A final instrument set matched to the core outcome 
set will be formed based on the consensus. In any areas 
where there is no consensus, the study team will adjudi-
cate, taking account of free text comments.
Data storage
Participants’ contact details, including email addresses 
and telephone numbers, and the answers they provide, 
will only be stored by Clinvivo for the duration of the 
study. Clinvivo will not share participants’ contact details 
with any third parties and participants’ answers will be 
stored anonymously. Data will be encrypted before being 
stored on Clinvivo’s server and prior to being transferred 
to the University of Glasgow. On completion of the study, 
Clinvivo will destroy all data after transferring it to the 
University of Glasgow. The University will securely store 
the data on password access computers for a period of 
10 years following completion of the research project.
dissemination
With regard to disseminating the results of our study, we 
will communicate our results via peer review publication, 
conference presentations, professional societies and also 
via our institution’s social media platforms.
In addition, we will submit a report to our funding body, 
the Chief Scientist Office of the Scottish Government 
Health Department. We will also share early findings with 
PHE and Health Scotland. We will be in full discussion 
with both bodies to ensure that our work informs their 
evaluation plans for BWMPs for adults with overweight 
and obesity.
Our study is, of course, restricted to the UK. This is 
due to BWMPs and their settings within health services 
being fairly country specific. For example, in France 
and the Netherlands there is no health insurance 
funding of BWMPs and, in the USA, obesity services are 
tertiary, combining behavioural programmes with medi-
cation and bariatric surgery. In addition, instruments, 
such as language and health economic models, can be 
country specific. Therefore, if used in an international 
context for trials or real-world services, our core outcome 
and definition/instrument set may require further 
adaptation.
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